2009
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
Kalb R, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. Journal Of The American Academy Of Dermatology 2009, 60: 824-837. PMID: 19389524, DOI: 10.1016/j.jaad.2008.11.906.Peer-Reviewed Original ResearchConceptsTreatment of psoriasisUse of methotrexateLiver biopsyNational Psoriasis Foundation Medical BoardAppropriate patient selectionNational Psoriasis FoundationEvidence-based studiesMedical boardsMethotrexate therapyPatient selectionRheumatoid arthritisTreatment optionsHepatic fibrosisRisk factorsConsensus conferencePsoriasisSide effectsEffective drugsLast guidelinesMethotrexateValuable optionTreatmentBiopsyTask ForceReport
2007
National Psoriasis Foundation Clinical Consensus on Disease Severity
Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ. National Psoriasis Foundation Clinical Consensus on Disease Severity. JAMA Dermatology 2007, 143: 239-242. PMID: 17310004, DOI: 10.1001/archderm.143.2.239.Peer-Reviewed Original ResearchConceptsNational Psoriasis Foundation Medical BoardConsensus statementSeverity criteriaClinical practiceClinical consensus statementTask ForceCategory of patientsNational Psoriasis FoundationCurrent clinical practiceMedical boardsPlaque psoriasisSevere psoriasisAppropriate therapyPsoriasis therapyClinical consensusInsurance payerDisease severityPsoriasisPatientsCurrent standardTherapyMedical professionalsSeverityExpert opinionMD